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Abstract
The Hap2/3/4/5 complex is a heme-activated, CCAATT binding, global transcriptional
activator of genes involved in respiration and mitochondrial biogenesis in the yeast species
Saccharomyces cerevisiae. Hap4 is the regulatory subunit of the complex and its levels
determine the activity of the complex. Hap4 is known to play a signaling role in response to
environmental conditions; however, little is known about the regulation of Hap4 levels or how it
responses to a cell’s functional state. The activity of the Hap2-5 complex is known to be reduced
in respiratory-deficient cells. In Liu Lab, it has previously been found that a link between Hap4
stability, mediated through 26S proteasome-dependent degradation, and dependence on
mitochondrial functional state plays a regulatory role on downstream targets of the Hap complex.
However, the mechanism behind this regulation is still largely unknown. In normally functioning
yeast cells, Hap4 is a highly unstable protein with a half-life of ~10 min. We have observed that
loss of mitochondrial DNA in respiratory deficient rho0 cells has a role in the further
destabilization of Hap4 to a half-life of ~4 min through the ubiquitin-proteasome pathway.
Through the screening of a collection of mutants defective in E2 ubiquitin-conjugating enzymes,
we show that Hap4 is greatly stabilized in ubc1Δubc4Δ double mutant cells. We also show that
Hap4 stabilization in the ubc1Δubc4Δ mutant leads to increased activity of the Hap2-5 complex,
indicating that mitochondrial biogenesis in yeast is regulated by the functional state of
mitochondria through ubiquitin/proteasome-dependent degradation of Hap4. Furthermore,
studies on Hap4 mutants involving two highly conserved cysteine residues led to a proposed
mechanism behind the regulation of Ubc4 activity towards Hap4 in response to changes in the
cellular redox state.
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Key Terms: Hap2/3/4/5 complex, Hap4, mitochondrial biogenesis, glucose repression, rho0, rho+
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Introduction

	
  

Saccharomyces cerevisiae as a model system
As one of the best-studied eukaryotic organisms, yeast is a major research reagent in
biological sciences. The duplicity of yeast, being one of the simplest eukaryotes, with genetic
complexity marginally greater than that of most prokaryotes (Sherman, 2002), while
simultaneously exhibiting high conservation of genes relative to mammalian cells, makes them
an invaluable model organism (Botstein, Chervitz, & Cherry, 1997). The budding yeast species
Saccharomyces cerevisiae is a well-established model organism in biology. As a non-pathogenic,
fast growing, readily and affordably available yeast species, it is a highly convenient model to
use in research (Sherman, 2002). Furthermore, protein structure homologies to mammalian
proteins, ease of manipulation, and high experimental pliability make S. cerevisiae an
archetypical model for research delving into the fundamental questions in biological sciences.
In 1996, the complete DNA sequence of S. cerevisiae’s ~6000-gene genome was released
in electronic form, making it the first eukaryotic species to have its genome completely
sequenced (Goffeau, et al., 1996). This pioneering event led to the use of S. cerevisiae as a
“model organism” for interpreting and understanding mammalian DNA sequences (Botstein,
Chervitz, & Cherry, 1997). The numerous structural and functional similarities in the genes and
their protein products encoded in S. cerevisiae’s genome to those of higher eukaryotes make
yeast a time and money efficient avenue for gaining insight into cellular mechanisms of higher
organisms. Over the years, the worth of S. cerevisiae has been further established, with it acting
as a valuable model for delving into underlying mechanisms of disease states in higher
eukaryotes.
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Yeast’s high experimental pliability allows for ease and comfort in the discovery process.
Its aptitude at up-taking and expressing genes through DNA transformation, which can either be
integrated into the yeast genome or exist as a multi- or single-copy replicative molecule in the
nucleus, has played a sizeable role in their usefulness as a system by providing means for indepth studies of genes and the proteins they encode (Mumberg, Muller, & Funk, 1995) (Botstein,
Chervitz, & Cherry, 1997). The well-defined genome of S. cerevisiae and protein homologies
pairs wonderfully with this system, allowing for experiments on gene regulation, protein assay,
genetic screening, random and targeted mutagenesis of specific genes, complete removal or
“knock-out” of targeted genes. All of these approaches have the capability of further illuminating
life on a molecular level.

The Metabolism of a Facultative Aerobe
Metabolism is the combination of anabolic and catabolic biochemical pathways for the
building and breaking down of biomolecules in a cell. Energy generation and carbon metabolism
are intimately connected in eukaryotic cells, with exothermic change from catabolic processes
often driving endothermic anabolic processes (Walker, 1998). The pathways behind carbon
metabolism are highly structured and complex, being mediated through a series of tightly
regulated branching enzymatic reactions. In yeast, carbon metabolism is intrinsically linked to
cell growth and proliferation as well as to basic cellular functions and vitality through energy and
metabolite production.
S. cerevisiae is a facultative aerobe. In the presence of a preferred carbon source such as
dextrose (glucose), it prefers fermentative metabolism through glycolysis and ethanol formation
over respiratory metabolism and oxidative phosphorylation. Through evolutionary innovation,
facultative aerobes have aquired the ability to utilize ethanol produced by fermentation as a
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carbon source by switching to aerobic respiration when fermentable carbon sources are depleted
(Botstein, Chervitz, & Cherry, 1997). The overview or these two pathways is shown in Figure 1
and a brief outline will be given for understanding of the key factors regulating these two
metabolic pathways.

Figure 1: Fermentation and Aerobic Respiration

	
  

This model summarizes the two main metabolic pathways of facultative aerobes:
Fermentative metabolism via glycolysis and fermentation and aerobic respiration via
the Tricarboxylic Acid (TCA) cycle and the Electron Transport Chain (ETC). These
two pathways are linked at two steps: with the conversion of pyruvate and/or ethanol to
Acetyl-CoA, which is oxidized through the TCA cycle.
	
  
During fermentative metabolism, glucose is broken down through glycolysis, a
ubiquitous catabolic pathway, with a title literally meaning, “splitting of sugar.” In this pathway,
which occurs in the cytosol, the six-carbon sugar glucose is broken down into two three-carbon
molecules of pyruvate through ten enzyme-catalyzed reactions. This process provides part of the
total cellular energy, producing two adenosine triphosphates (ATP) per glucose molecule by way
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of substrate level phosphorylation. In the sixth step of glycolysis, the oxidized form of
nicotinamide adenine dinucleotide (NAD+) is reduced to NADH by the transfer of hydrogen
from glyceraldehyde phosphate by the enzyme glyceraldehyde 3-phosphate dehydrogenase. The
overall reaction of glycolysis thus produces two moles of ATP, two moles of pyruvate, and two
moles of the reduced NADH from one mole of glucose.
For continuation of glycolysis, NAD+ must be regenerated through oxidation of the
NADH produced by glycolysis. S. cerevisiae utilize alcoholic fermentation, in which pyruvate is
converted to ethanol and carbon dioxide for the regeneration of NAD+ (Morton, 1980). This
occurs in a two-step reaction whereby pyruvate is first decarboxylated by the enzyme pyruvate
decarboxylase to form acetaldehyde, which is then reduced by NADH to form NAD+ as
catalyzed by a second enzyme, alcohol dehydrogenase (Walker, 1998). Glycerol is also
generated in this pathway from dihydroyacetone phosphate and later, as a non-fermentable
carbon source, can be utilized in respiration (Morton, 1980).
Aerobic respiration occurs in the mitochondria. As the catabolic process with the highest
efficiency for ATP production, it is the principal metabolic pathway for Gibbs free energy
production in most eukaryotic cells (Raghevendran, Patil, Olsson, & Nielsen, 2006). The overall
pathway can be broken down into two metabolic pathways: the citric acid cycle, also known as
the Tricarboxylic acid (TCA) or Krebs cycle, and the mitochondrial electron transport chain
(ETC). During respiration NADH produced in the TCA cycle is oxidized by oxygen through the
electron transport chain with concomitant generation of a proton (H+) gradient across the
mitochondrial inner membrane, which drives ATP production through the F1F0-ATPase.
In 1937, Hans Krebs provided the early insights that led to the historical discovery of the
circular pathway whereby the acetyl group of acetyl-CoA is oxidized into two molecules of
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carbon dioxide through a series of eight highly conserved enzymatic reactions (Krebs, 1937). An
overview of the TCA cycle with these eight enzymes and the 13 nuclear genes in S. cerevisiae
that encode them are shown in Figure 2.
	
  

Figure 2: The TCA Cycle in S. cerevisiae
	
  
A diagram of the TCA cycle intermediates and the yeast genes encoding the enzymes that
catalyze the reactions. Substrates are shown in bold, while genes encoding the TCA cycle
enzymes are shown in uppercase italic font. Of these enzymes, those with a rate-controlling role
of the cycle are denoted by a line beneath their gene name.

The first substrate of the cycle, acetyl-CoA, can be produced from pyruvate through
oxidative decarboxylation by the multi-enzyme complex pyruvate dehydrogenase in the
mitochondria matrix. This is the linking step between glycolysis and the TCA cycle. However, in
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yeast, acetyl-CoA is largely synthesized from ethanol produced during alcoholic fermentation.
This occurs by way of three enzyme-regulated steps whereby ethanol is oxidized to
acetaldehyde, which is sub-sequentially converted to acetic acid. Acetic acid is, in turn,
converted to acetyl-CoA through a reaction requiring ATP.
The FADH2 and NADH produced in the TCA cycle act as electron carriers and are
important in providing electrons for the next step of respiration, the electron transport chain
(ETC), which harnesses free energy for the formation of ATP via oxidative phosphorylation.
ATP synthesis occurs in the matrix of the mitochondria, where mobile and integral protein
complexes act as electron carries, transporting electrons from NADH and FADH2 to a final
electron acceptor. In the case of aerobic respiration, this is O2. During this transfer, the electrons
are shuttled from redox centers with more negative reduction potentials to those of more positive
and relative greater values. These values correlate to greater affinity for electrons, thus this
shuttling produces free energy as overall exergonic process (Voet, Voet, & Pratt, 2010).
In the ETC, there are four protein-lipid enzyme complexes located in the mitochondrial
inner membrane containing flavins, quinoid compounds, and transition metal compounds, which
act as electron carriers through redox reactions. In mammalian cells, these enzymes and their
associated electron carriers are titled: complex I (NADH:ubiquinone oxidoreductase), complex II
(succinate: ubiquinone oxidoreductase or succinate dehydrogenase), complex III
(ubiquinol:ferrocytochrome oxidoreductase), and complex IV (cytochrome c oxidase). Electrons
enter the electron transport chain through the oxidation of NADH to NAD+ at Complex I and
FADH2 to FAD+ at Complex II, the latter which is also the sixth enzyme in the TCA cycle.
Complex I of mammalian cells is composed of 46 different subunits, 7 of which are encoded by
mitochondrial DNA (Vilain, et al., 2012). Interestingly, yeast cells do not contain these multi-
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subunit NADH-quinone oxidoreductases, rather they have a single protein, NADH
dehydrogenase encoded by NDI1, which transfers electrons from NADH to ubiquinone in the
respiratory chain without pumping protons (Vilain, et al., 2012).
The ETC is linked to ATP synthesis through a theory proposed by British biochemist,
Peter Michell in 1961, titled the chemiosmotic theory (Mitchell, 1978). This theory, which won
Michell the Nobel Prize in Chemistry in 1978 “for his contribution to the understanding of
biological energy transfer” (Nobel Media), was first received with much skepticism, but came to
be accepted as one of the fundamental processes in all living systems from plants to humans. It
states, the proteins of electron transport and ATP-synthesizing systems are localized in a
membrane with a well-defined orientation and are functionally linked to a directional transfer of
protons (H+), across the membrane (Mitchell, 1978). In eukaryotes, this occurs in mitochondria,
via pumping of protons from the matrix into the intermembrane space at complexes I (except in
yeast and other fungi), III, and IV, creating an electrochemical proton gradient across the inner
mitochondrial membrane, the latter is then harnessed by the F1F0-ATP synthase for the
production of ATP.
As shown in Figure 1 fermentation and aerobic respiration each require their own
enzymatic mechanisms and cellular machinery. Thus, the switch between fermentation and
respiration requires a remodeling of gene expression, resulting in a characteristic growth pattern
titled “diauxic shift” (Santangelo, 2006) (DeRisi, Lyer, & Brown, 1997). As the title implies, the
diauxic shift refers to a two-sided curve that reflects the cells growth pattern as cells utilize a
preferred carbon source first and then undergo remodeling of their metabolic pathways for the
use of the second, and less preferred carbon source (Walker, 1998). In S. cerevisiae, this
metabolic remodeling involves the use of non-fermentable carbon sources, such as lactate,
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ethanol, glycerol, and pyruvate in respiration. This metabolic switch is regulated in response to
external glucose levels, in a method that adjusts the energy metabolism in a process that is
generally referred to as glucose repression (Rodrigues, Ludovico, & Leao, 2006).
By definition, glucose repression refers to the phenomenon whereby cells grown on
glucose repress the expression of a large number of genes that are required for the metabolism of
alternate carbon sources (Trumbly, 1992). Due to a preference for fermentative metabolism in S.
cerevisiae, glucose repression affects the expression of enzymes required for metabolism of nonfermentable carbon sources as well as enzymes involved in respiration and mitochondrial
biogenesis (Rolland, Winderickx, & Thevelein, 2002). This is a highly regulated process,
involving gene and protein regulation at multiple levels in a number of signal transduction
pathways. Energy metabolism is dependent on a few transcription factors, which regulate cellular
processes by controlling the expression of multiple genes involved in a given cellular pathway.
Transcription factors are key elements in regulating the expression of target genes (Fendt &
Uwe, 2012). One of these transcription factors in S. cerevisiae is the Hap2-5 complex, which is
an essential part of yeast’s metabolic remodeling when entering respiratory growth and is
responsible for the activation of roughly a hundred genes involved in respiration and other
metabolic functions (Pinto & McNabb, 2005).

The Hap2/3/4/5 Complex
The majority of the genes encoding mitochondrial proteins are encoded in the nuclear
genome. In yeast, the expression of these genes becomes de-repressed during the diauxic shift.
This de-repression is principally regulated by a family of heme-activated proteins, known as
Hap proteins (Liu & Butow, 1999). The Hap proteins are transcription factors that bind to DNA
at distinct upstream activation sites (UAS) of genes involved in respiration and regulate their
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transcription. These proteins are mainly responsible for the transcriptional regulation of
respiration, and do so by controlling the expression of multiple genes encoding the proteins
involved in respiration, such as components of the electron transport chain and the enzymes of
the TCA cycle.
As their names imply, Hap proteins’ activity depends on the cofactor heme. Heme is an
iron-containing heterocyclic prosthetic group with electron carrying properties and a high
affinity for oxygen. Its cellular concentration is linked to oxygen availability through its
biosynthesis, which is oxygen-dependent (Kwast, Burke, & Poyton, 1998). Heme is known to
regulate the activity of a diverse group of proteins, with heme-regulated signal transducers being
found in organisms ranging from bacteria to humans (Zhang, et al., 2007). Heme is involved in
oxygen sensing, acting as a positive modulator for the transcription of the aerobic genes and as a
negative modulator for the transcription of the hypoxic genes (Kwast, Burke, & Poyton, 1998).
Therefore, heme acts as an intermediary in the regulation of the expression of genes involved in
respiration and thus oxidative phosphorylation. In S. cerevisiae, this regulation is accomplished
through the HAP family. There are two components to the HAP system: Hap1 and the
Hap2/3/4/5 complex. Together these two transcription factors represent an important mechanism
for global control of the expression of key components in respiratory metabolism.
Hap1 was first identified as an activator of the hypoxic gene iso-cytochrome C gene
(CYC7) in 1969 and termed CYP1. However, the gene was later re-designated based on the
discovery in 1986 that it was the same protein reported as Hap1, an activator of CYC1 expression
(reviewed by Kwast, Burke, & Poyton, 1998). Analysis of the upstream regulation of CYC1
expression led to the identification of two distinct upstream activation sequences, UAS1 and
UAS2 (Pfeifer, Prezant, & Guarente, 1987) (Lalonde, Arcangioli, & Guarente, 1986). Upstream
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activation sequences (UAS) are cis-acting elements upstream of TATA boxes, which act as a
primary cellular loci for gene-specific regulation (Lalonde, Arcangioli, & Guarente, 1986). Hap1
is responsible for the regulation at UAS1 of the CYC1 gene and it is also targeted to genes
encoding the proteins involved in heme biosynthesis, electron transfer reactions and controlling
oxidative damage (Gaisne, Becam, Verdiere, & Herbert, 1999) (Zhang & Hach, 1999). The other
component of the Hap family, the Hap2-5 complex, regulates the transcription of genes involved
in mitochondrial biogenesis and oxidative phosphorylation by acting on the CCAAT element .

Figure 3: Hap2-5 Target Genes

	
  

A model for the role of the Hap Pathway in controlling the expression of genes involved in the TCA
cycle and ETC. When the Hap pathway is activated the expression of key components of respiration
increases and mitochondrial function and biogenesis is optimized as under the control of the Hap
pathway.

As a global transcriptional activator, the Hap2-5 complex is responsible for the activation
of about 100 genes responsible for respiration and other metabolic functions (Pinto & McNabb,
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2005). Included in this group are genes encoding key enzymes in oxidative phosphorylation and
mitochondrial biogenesis (Figure 3). These are required for respiration, with deletion or
malfunction of any one of these subunits rendering cells unable to grow on non-fermentable
carbon sources (Olesen, Hahn, & Guarente, 1987) (Bourgarel, Nguyen, & Bolotin, 1993). In derepressed cells that are grown in low glucose media and that contain respiratory-competent
mitochondria, the Hap2-5 complex is required for transcriptional activation of genes encoding
key enzymes of the TCA cycle, including: KGD1 (encoding the E1 component of α-ketoglutarate
dehydrogenase), IDH1 and IDH2 (encoding the subunits of isocitrate dehydrogenase), SDH1
(encoding the flavoprotein component of succinate dehydrogenase), FUM1 (encoding the
enzyme fumarate hydratase), and MDH1 (encoding malate dehydrogenase) (Liu & Butow,
2006). Additionally, CYC1 (encoding cytochrome c, isoform 1), CYT1 (encoding cytochrome
c1), CIT1 (encoding the mitochondrial isoform of citrate synthase), KGD2 (encoding the E2
component of mitochondrial α-ketoglutarate dehydrogenase complex), QCR8 (encoding a
subunit of the ubiquinone:cytochrome c oxidoreductase complex) and SDH2 (encoding the ironsulfur protein subunit of the succinate dehydrogenase complex) are also reported to be target
genes of the Hap2-5 complex (Schüller, 2003).
The Hap2-5 complex binds to the 5’-CCAAT-3’ consensus sequence in the promoter of
target genes and is thus also known as the CCAAT-binding factor (CBF) complex in yeast.
CBF’s exist in many species and represents a conserved mechanism of heterologous gene
regulation (Mantovani, 1999). The type and number of genes regulated by CBF’s vary, but the
5’-CCAAT-3’ consensus sequence that they bind to is conserved (Mantovani, 1999). Hap2,
Hap3, and Hap5 each contain a core domain that is highly conserved during evolution and is
required for DNA binding and subunit association. Among the four protein of the Hap2-5
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complex, Hap2 was discovered first and its identification led to the discovery of Hap3 (Olesen,
Hahn, & Guarente, 1987). Hap5 is required for interaction between Hap2 and Hap3, and thus the
assembly and DNA-binding activity of the complex (McNabb, Xing, & Guarente, 1995) (Pinto
& McNabb, 2005). The DNA binding domain of the Hap2-5 complex is located on the Hap2 and
Hap3 subunits. These two subunits are functionally conserved in mammalian CBF (McNabb,
Xing, & Guarente, 1995) (Xing, Fikes, & Guarente, 1993).
On the other hand, the Hap4 subunit of the complex is not required for DNA binding, but
it is the regulatory subunit, with its levels determining the activity of the complex (Forsburg &
Guarente, 1989)(Olesen & Guarente, 1990). In cells grown in low levels of glucose, HAP4
expression is induced, leading to high levels of Hap4 and its migration into the nucleus, and the
resultant activation of the Hap2/3/4/5 complex (as shown in Figure 5) (Liu Lab Unpublished
Results). This activation is accomplished by two transcriptional activation domains one in the
carboxyl- and one in the amino-termini (Stebbins & Triezenberg, 2004) (Forsburg & Guarente,
1989). The C-terminus contains a highly acidic region, a common characteristic of
transcriptional activators (Forsburg & Guarente, 1989). HAP4 expression is affected by the
functional states of the mitochondria. In cells with robust mitochondrial respiratory activity,
Hap4 expression is high, while in cells with dysfunctional mitochondria, for example due to loss
of mitochondrial DNA as in rho0 petites, Hap4 expression is reduced (Ozcan, Dover, & Johnston,
1998).
As the regulatory subunit of the complex, Hap4 is an ideal point of focus for the study of
regulation of the Hap pathway. Despite its central role in respiratory metabolism and
mitochondrial biogenesis, little is known about the mechanism behind HAP4 expression and how
Hap4 levels are regulated. Further studies on the regulation of Hap4 levels could provide new
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insights into the regulation of this important pathway. Regulation of Hap4 protein levels is the
focus of this thesis.

Mitochondrial Biogenesis
	
  
Mitochondria are thought to have once existed as independent organisms. Their evolution
into their current role as a cellular organelle is explained by the endosymbiotic theory, which
postulates that mitochondria began as independent bacteria that were ingested through
endosymbiosis. One important piece of evidence in support of this theory is that mitochondria
still contain their own circular genome, known as mtDNA. Though most of the proteins utilized
in the mitochondrial pathways are encoded in the nuclear genome, mtDNA contains 15,00018,000 base pairs depending on the species. These base pairs are responsible for approximately
thirteen protein-encoding genes required for respiration. However, the majority of genes
involved in respiration are not located in mtDNA and are instead encoded in the nuclear genome.
The remainder of the mitochondrial genome encodes the machinery necessary for translation of
mtDNA. Mitochondrial number and function are altered in response to external stimuli; this is
mediated through coordinated expression of genes encoded in the nuclear and mitochondrial
genome. This coordinated expression is regulated by transcription/replication factors such as the
Hap2-5 complex.
From the genetic standpoint, the respiratory chain is a unique cellular structure, being
formed by means of the complementation of two separate genetic systems: the nuclear genome
and the mitochondrial genome (Zeviani & Donato, 2004). Thus, one fundamental question in the
biological sciences is how the coordinated expression between these two genomes occurs. For
coordinated expression, cells must have a mechanism of sensing the state of the mitochondria
and leading to changes in nuclear gene expression accordingly. The budding yeast is an ideal
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organism for studying the signal transduction pathways involved in mitochondrial biogenesis: it
is viable in rho0 (no mtDNA) and rho- (mutant mtDNA) states. Mitochondrial biogenesis is often
studied through research on the regulation of key factors controlling the biosynthesis of the
enzyme complexes of oxidative phosphorylation. This is often carried out by the same factors
regulating the expression of genes implicated in glucose derepression, such as the Hap proteins.
	
  

The Ubiquitin-Protease System
Protein levels are controlled at transcriptional and post-translational levels. The ubiquitinprotease system (UPS) is the main degradation pathway in the cytosol in all eukaryotes and is
key in post-translational regulation of protein levels (Seufert & Jentsch, 1990). Protein
degradation is the breaking down of proteins via proteolysis, namely the breaking of peptide
bonds. This is an important regulatory process that allows cells to dispose of mis-folded or
damaged proteins, as well as to control the concentration of proteins within the cell by selective
degradation. Selective degradation is key to the control of cellular signal transduction and
regulation of cellular pathways by modulation of the levels of key regulatory factors
(Hochstrasser, 1996). Through this method, the UPS controls multiple pathways by regulating
the stability of target proteins that govern specific cellular function, including the cell cycle, class
I antigen processing, transcriptional regulation, signal transduction pathways, receptor down
regulation, and receptor- mediated endocytosis (Hochstrasser, 1996). Malfunction in this system
leads to a number of disease states and pathological disorders including Alzheimer’s,
Huntington’s, Parkinson’s, and malignant transformation linked to cancer (Davies, Sarkar, &
Rubinsztein, 2007) (Schwartz, 1999). Understanding of the factors regulating the UPS in
targeted degradation thus has practical application in the cellular viability and disease
mechanism.
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In 2004, Aaron Ciechanover, Avram Hershko, and Irwin Rose won the Nobel Prize in
Chemistry for their work on the discovery of the UPS. The UPS involves poly-ubiquitination of
proteins through covalent binding of ubiquitin molecules to a target protein in an ATP-dependent
manner at specific lysine residues for its subsequent degradation through the 26S proteasome
(Figure 4) (Tongaronkar, Li, Lambertson, Ko, & Madura, 2000). Three types of enzymes
catalyze the covalent attachment of ubiquitin to its target protein, which, with increasing
specificity, ensure a system with the high degree of selectivity toward its many substrates
(Ciechanover, Orian, & Schwartz, 2000). These are: ubiquitin-activating enzymes (E1),
ubiquitin-conjugating enzymes (E2) and ubiquitin ligases (E3).

	
  

Figure 4: The Ubiquitin-Proteasome System
A simplified model of the Ubiquitin-Proteasome System. Whereby, a target protein is
polyubiquinated by repeated cycling through a three enzyme (E1, E2, and E3) cascade for its
eventual targeting to the 26S-Proteasome for degradation.	
  

The UPS starts with ubiquitin’s activation by E1 in an ATP-dependent reaction, which
resulting in the linking of ubiquitin to E1 by means a high-energy thioester bond at a highly
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conserved cysteine residue. Ubiquitin is then transferred to E2, where it forms a thioester bond at
a conserved cysteine residue on the surface of E2. Then, ubiquitin is transferred to a targeted
protein substrate as facilitated by E2 and E3, which together catalyze the isopeptide bond
formation between ubiquitin and a lysine residue(s) on the substrate (Hochstrasser, 1996). This
enzyme cascade is repeated to form a chain of isopeptide-linked ubiquitin on the substrate, a
structure that targets the protein to the 26S proteasome complex, a large, multi-protein complex
that catalyzes proteolysis of the ubiquitinated protein.
Polyubiquitination of target proteins is a highly regulated process and varies greatly
among substrate proteins. While much is known about the overall mechanism of the UPS, the
exact signals that target specific proteins for degradation remain to be discovered in many signal
transduction pathways. A few of the known factors that affect the regulation of protein turnover
include: phosphorylation as a signal for ubiquitination (as in the case of Mos, oocyte protein
kinase and beta-catenin and NF-κB regulatory protein IκBα), glucose ( as with fructose
bisphosphate in yeast), glycosylation (for the elimination of denatured glycoproteins), amino
acid starvation (as for Gcn4 a transcription factor in yeast), and even red light ( seen in
Phytochrome, a plant light-responsive receptor) (Hochstrasser, 1996) (Hunter, 2007) (Orford,
Crockett, Jensen, Weissman, & Byers, 1997).
The enzymes of the UPS are highly conserved in all eukaryotic cells, though the number
and variety is more complex in mammalian cells as compared to lower eukaryotic organisms.
Though there are many homologues between yeast and mammalian E2’s, the terminology is
completely different and does not reflect the functional or structural homologies (Glickman &
Ciechanover, 2002). In S. cerevisiae there exists a single E1, designated (UBA1), thirteen E2’s
(UBC), and an unknown number of E3’s. Of the thirteen identified E2’s in the yeast genome,
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two, Ubc9 and Ubc12, do not conjugate to ubiquitin, but are nonetheless considered part of the
UBC family.
As stated previously, Hap4 levels are dramatically decreased in cells with dysfunctional
mitochondria as compared to those with robust mitochondrial respiratory activity (Figure 5).
This change in protein level is not fully explained by HAP4 transcription, indicating that Hap4
might be subject to posttranslational regulation (Capps, 2011) (Ozcan, Dover, & Johnston,
1998).

Figure 5: Hap4 Activity in Response to Dysfunctional Mitochondria
A model for the regulation of the Hap2-5 complex. To the right are de-repressing conditions
under which Hap4 levels are high, leading to its migration into the nucleus for interaction with
the Hap2/3/4/5 complex for its activation and, consequently, the transcription of genes involved
in respiratory growth. To the left are repressing conditions under which Hap4 is inhibited by high
glucose and some unknown mechanism in cells with dysfunctional mitochondria, leading in turn
to a downregulation of the HAP pathway and respiratory growth.
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Materials and Methods
Media and Growth Conditions
Yeast strains were grown in media at 30˚C. The media used were: YPD medium (1%
Bacto-yeast extract, 2% Bacto-Peptone, 2%dextrose), YNB medium (0.67% yeast nitrogen base)
supplemented with 1% Casamino Acids, 5% or 2% dextrose (YNBcasD) or 2% raffinose
(YNBcasR) (Amberg, Burke, & Strathern, 2005). For plates, agar was used as well (2% BactoAgar). When required, tryptophan (30 mg/liter) was added to YNBcasD or YNBcasR media to
allow trp1 mutant cells to grow.
Yeast Strains
All yeast strains used in this project were of one of two parent strain backgrounds: Y000
(MATa his3-Δ200 leu2-3,2-112 lys2-801 trp1-1(am) ura3-52) or BY4741 (MATa ura3Δ leu2Δ
his3Δ1 met15Δ). Specific strains that were used in rho0 mutant generation and plasmids for
transformation were all acquired from Liu Lab stock.
Yeast Expression Plasmids for Constructing Epitope Tagged Proteins
In this project, two yeast expression vectors were used as plasmid templates: pRS414
(TRP1) and pRS416 (URA3) (Mumberg, Muller, & Funk, 1995). The gene encoding the protein
under investigation was fused at its 3’-end, to a DNA sequence encoding a 10-alanine linker and
a epitope tag (-myc3 or –HA3).
Generation of strains lacking mtDNA (rho0)
Respiratory capable, rho+ yeast strains were treated with ethidium bromide (EB), a
mutagenic known to preferentially intercalate into mtDNA. To generate rho0 cells, rho+ cells
were grown in YPD medium supplemented with 15 ug/ml EB at 30˚C to saturation. Cultures
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were streaked out on YPD plate to obtain single colonies. Single colonies were then streaked on
to YPGlycerol plates and YPD plates. Cells lacking mtDNA were selected for by growth
phenotype, as rho0 cells unable to form colonies on YPGlycerol plates (due to inability to
undergo respiration). Loss of mtDNA was further verified by 4,6-‐diamidino-‐2-‐phenylindole
(DAPI) staining of individual colonies and fluorescence microscopy using MetaMorph computer
program.
Yeast High-efficiency Transformation
Fresh cells were inoculated in rich YPD media (or appropriate selective media) using a
sterile loop to OD ~0.2. Cells were incubated 30˚C for 3-5 hours with agitation. Cells were
harvested by centrifuge and re-suspended in 0.1M LiOAc. Cells were incubated with plasmid
DNA and transformation mix (single strand DNA, LiOAc, PEG) at 42°C for 60 minutes. Cells
were then plated on selective media to select for transformants.
Protein Collection
Yeast strains were transformed with plasmids containing the gene encoding the protein of
interest with an epitope tag. Cells were lysed using extraction buffer (18.5% 10N NaOH, 7.4%
beta-mercaptoethanol) on ice for 10-30 min. Total cellular proteins were collected through
precipitation using 8% trichloroacetic acid. Pellets were neutralized using 1M unbuffered Tris
and boiled in SDS-PAGE loading buffer for 4 min. For samples where cysteine bond formation
was examined, samples were collected using extraction buffer lacking β-Mercaptoethanol.
Immunoblotting (Western Blotting)
Proteins were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). Protein loading was balanced based on the OD600 readings of cultures before
collection. For samples in which cysteine bond formation was to be examined, urea (8M) was
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used for denaturing and DTT was omitted to prevent reduction of disulfide bonds. Proteins were
transferred to nitrocellulose membranes by electroblotting. For immunoblotting, nitrocellulose
membranes were probed with primary antibody, either rat monoclonal high affinity anti- HA IgG
or mouse monoclonal anti-Myc anti-body in 1X TBS-Tween solution with 5% milk powder.
Membranes were then probed with HRP-conjugated goat anti-rat, goat anti-mouse, or goat antirabbit antibody. Chemiluminescence was produced using the ECL reagent and images were
captured using the Bio-Rad Chemi-Doc system. For loading controls, membranes were stripped
in deprobing buffer (67.5 mM Tris-HCl, pH 6.7, 2% SDS, 0.08% β-mercaptoethanol) at 60°C for
30 min and reprobed with rabbit polyclonal anti-Pgk1antibody (ubiquitous and stable protein
phosphoglycerate kinase) .
PCR mutagenesis of Cysteine to Serine mutant of Ubc4
Polymerase Chain Reaction (PCR) SOEing was utilized to carry out site-directed
mutagenesis. To this end, primers were designed with nucleotide mismatches for the introduction
mutation of cysteine residue 22 to serine (C22S) or cysteine residue 108 to serine (C108S) by
point mutation of guanidine to cytosine (Figure 6). Mutants were confirmed by sequencing.
Plasmids containing confirmed mutations were transformed into respective yeast strains and
selected for as outlined in Yeast High Efficiency Transformation.
Codon:

Mutanagenesis

TGT

TC T

O

Amino Acid:

O
OH

HS

OH

HO

NH 2

NH 2

Cysteine

Serine

Figure 6: Point Mutagenesis of Cysteine Residue to Serine
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Cycloheximide Chase Analysis
Cells were grown overnight in liquid YNBcas5%D or YNBcasRaff medium to log phase
(OD600 0.6~0.8). Before cycloheximide treatment, 1.0 ml culture was collected as zero time
point. Cycloheximide was used to inhibit protein synthesis by acting on the ribosome to prevent
translation. At fixed time intervals (five or ten min.), 1.0 ml culture was collected for generating
total cellular extracts. Proteins of interest were visualized by Immunoblotting. Two to three
independent experiments were carried out and scrutinized for reproducibility. Quantification was
carried out using Bio-Rad QuantityOne software and protein half-life (T1/2) was calculated using
Microsoft Excel.
β-Galactosidase Assay
Plasmids expressing a lacZ gene fused to the promoter of the gene under analysis were
transformed into yeast strains. Cells were grown to undergo a minimum of six generations and
collected at OD600 0.6-0.8. β-galactosidase assays were carried out as described (Amberg, Burke,
& Strathern, 2005). Briefly, cells were collected by centrifugation and resuspended in breaking
buffer (100 mM Tris-HCl, pH 8, 1 mM dithiotreitol, 20% glycerol). Samples were stored at -20
°C until assay was conducted. For assays, cells were thawed on ice and treated with 1 mM
phenylmethylsulfonyl fluoride [PMSF] to prevent protein degradation. Total cellular extracts
were obtained by vortexing in the presence of glass beads (0.45-0.50 mm). β-galactosidase
activities of a lacZ reporter gene were reported in nanomoles of colorimetric product onitrophenyl-β-d-galactopyranoside [ONPG] per milligram of protein per minute. Specific activity
was calculated in relation to the total protein amount in the initial extract, determined using the
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Bradford assay. For each plasmid-strain combination, two or three independent cultures were
grown and β-galactosidase activities were determined.
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Results
	
  

Preliminary Findings from Liu Lab
As reported by Denise Capps in her thesis for the requirements for a degree of Master of Science
in Biological Sciences at the University of New Orleans (Capps, 2011).
Mitochondrial Functional State Regulates Hap2-5 Pathway Activity
In previous experiments from Liu Lab, it has been reported that expression of KGD1, a
Hap2-5 complex reporter gene, is reduced in rho 0 cells. The KGD1 activity is similar to that seen
in a hap4 deletion mutant, where the pathway is inactivated, suggesting the Hap2-5 pathway is
down regulated in response to compromised mitochondrial function. The promoter activity of
Hap4 was also found to be down regulated in rho0 cells, however only a 2.5-fold decrease from
rho+ to rho0 was observed, leaving the question of where the discrepancy in pathway activity and
HAP4 expression is originating. Hap4 protein levels were examined using Western blotting and
found to show a six-fold decrease from rho+ to rho0 cells. The discrepancy in HAP4 promoter
activity and Hap4 protein levels suggest that Hap4 is subject to post-transcriptional regulation. It
was then found that Hap4 is highly unstable in rho+ cells. In rho0 cells, Hap4 instability is
further increased. Hap4 instability was found to be mediated through proteasome-dependent
degradation.

Goals of Research
The overall objective of my research is to understand the cellular mechanisms regulating
the coordinated expression of genes involved in mitochondrial biogenesis and oxidative
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phosphorylation between mitochondria and the nuclear genome. A fundamental question is how
cells sense functional states of mitochondria and adjust nuclear gene expression accordingly,
thus coordinating the expression of genes between the two genomes. Hap4, the regulatory
subunit of the Hap2-5 complex in this pathway, is the focus of my study. More specifically, my
central focus is on how Hap4 degradation is regulated through the Ubiquitin-Proteasome system
and the mechanism underlying the increased degradation of Hap4 in rho0 cells.

Research Results
Hap4 has increased instability in rho0 cells, as compared to rho+ cells
Hap4 is a highly unstable protein (Capps, 2011). To confirm that Hap4 is further
destabilized in cells lacking functional mitochondria, rho+ and rho0 cells containing a plasmid
encoding 3xHA-tagged Hap4 were assayed for Hap4 stability using cycloheximide chase and
immunoblotting. The results of this experiment are shown in Figure 7.
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Figure 7: Analysis of Hap4 Stability by Cycloheximide Chase
(A) Strains containing a HAP4-HA plasmid were assayed for Hap4 stability using cycloheximide
chase and immunoblotting. (B) Hap4 levels in panel A were determined using Bio-Rad
QuantityOne software and the half-life (T1/2) of Hap4-HA was calculated using Microsoft Excel.
	
  
Consistent with Denise Capps’s result, Hap4 is an unstable protein in cells with normal
functioning mitochondria (rho+ cells), with an estimated half-life of ~10 minutes. In cells with
dysfunctional mitochondria (rho0 cells), Hap4 is greatly destabilized, with an estimated half-life
of ~4 min. Based on these results, it is clear that there exists some cellular mechanism by which
Hap4 stability is regulated by the functional states of mitochondria.

Hap4 is stabilized in a ubc1Δubc4Δ double mutant
To identify the ubiquitin-conjugating (Ubc) enzyme(s) responsible Hap4 degradation in
rho0 cells, I analyzed Hap4 stability in a collection of fifteen strains lacking designated Ubc
enzymes as described in Figure 8. To this end, all mutant strains were acquired from Liu Lab
Yeast Stock and rho0 petite derivatives of the mutants were generated as described in Materials
and Methods. These rho0 cells were transformed with plasmids encoding 3xHA-tagged HAP4
and transformants were analyzed for Hap4 stability using cycloheximide chase. Figure 8 shows
that only a ubc1 ubc4 double mutation greatly stabilizes Hap4, indicating that Ubc1 and Ubc4
play a redundant role in mediating ubiquitin-proteasome dependent degradation of Hap4.
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Figure 8: Analysis of Hap4 Stability in ubc Mutants by Cycloheximide chase
Rho wild-type and isogenic ubc mutant cells were grown in YNBcasR media to mid-log phase
and Hap4 stability was analyzed by cycloheximide chase and immunoblotting. Pgk1 protein
levels were determined using anti-Pgk1 antibody and included as loading controls.
0

Hap4 stabilization in ubc1Δubc4Δ mutant cells under various conditions
We next examined the effect of a ubc1 ubc4 double mutation on Hap4 stability in rho+ cells
grown in YNBcasR media and in both rho+ cells and rho0 cells grown in YNBcasD media. I
found that Hap4 is stabilized in ubc1 ubc4 double mutant cells under all four conditions (rho+,
rho0, YNBcasR, YNBcasD) (Figure 9). These data suggest that Ubc1 and Ubc4 play a housekeeping role in turning over Hap4. However, they do not exclude the possibility that the activity
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Figure 9: Hap4 Stability in ubc1Δub4Δ mutant
Rho and rho wild-type and isogenic ubc1 ubc4 mutant cells were grown in YNBcasD or
YNBcasR media and Hap4 stability was analyzed by cycloheximide chase and immunoblotting.
Pgk1 was used as loading controls.
+

0

Hap4 stabilization due to a ubc1Δubc4Δ double mutation correlates with increased
expression of Hap2-5 target genes
Hap4 is stabilized in a ubc1 ubc4 double mutant, however the question remains of does
Ubc1/4-dependent degradation of Hap4 affect pathway activity. To this end, the expression of
two Hap2-5 target genes, KGD1 and SDH1, was analyzed in rho+ wild-type and isogenic
ubc1Δubc4Δ double mutant cells grown in YNBcasD media. Figure 10 shows that expression of
a lacZ reporter gene under the control of KGD1 or SDH1 promoter is increased ~6-fold in ubc1
ubc4 double mutant cells compared to wild-type cells. To determine whether an increase in the
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expression of KGD1- and SDH1-lacZ reporter genes in the ubc1 ubc4 mutant is Hap4-dependent,
their expression was analyzed in a hap4 single mutant and a ubc1 ubc4 hap4 triple mutant.
Figure 10 shows that a hap4 mutation largely abolishes increased expression of KGD1- and
SDH1-lacZ reporter genes in the ubc1 ubc4 mutant. Together, these data indicate that Ubc1/4-

E-galactosidase activity (nmols/min/mg protein)

dependent degradation of Hap4 negatively regulates the expression of Hap2-5 target genes.
160
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Figure 10: Hap2-5 Pathway Activity is Up-Regulated by Hap4 Stabilization
160 isogenic hap4 single, ubc1/4 double and ubc1/4 hap4 triple mutant cells
Rho wild-type and
WT
carrying either a140
KGD1-lacZ or a SDH1-lacZ fusion gene were grown in YNBcasD media and βubc1/4'
galactosidase activities were determined as described in Methods
and Materials.	
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60 to a ubc4 ubc5 double mutant
robust cell growth
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Ubc4 and Ubc5 share three highly conserved cysteine residues. Of the three, one is the
20

catalytic residue and
the other two serve no known function. Cysteine residues are among the
0

KGD1-lacZ

SDH1-lacZ

least common amino acid residues and are known to be involved in sensing the redox
environment of the cell. A loss in the mitochondrial respiratory function might affect the redox
balance in the cell, which in turn might affect the activity of Ubc4 towards Hap4. To test this
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possibility, the conserved non-catalytic cysteine residues at the 22nd and 108th positions of Ubc4
were mutated to a serine residue and the resulting mutants will be referred to as C1S and C2S for
C22S and C108S mutations, respectively. We determined whether Ubc4(C1S) and Ubc4(C2S)
mutants are functional based on their ability to restore fast cell growth to a ubc4 ubc5 double
mutant (Figure 11). A ubc5Δ single deletion mutant that expresses wild-type Ubc4 shows robust
growth. In contrast, in cells lacking both Ubc4 and Ubc5, the growth is strongly reduced. In ubc4
ubc5 double mutant cells transformed with a plasmid encoding myc-tagged UBC4, robust cell
growth is largely restored. This growth is matched by the ubc4(C1S) and ubc4(C2S) mutants,
indicating that these two mutants are functional.

pUBC4-myc3
vector

ubc4/5'

ubc4/5'

ubc4/5'
vector

pUBC4(C1S)-myc3

ubc4/5'

ubc5'

pUBC4(C2S)-myc3

Figure 11: ubc4 Cysteine to Serine Mutant Functionality
Plasmids encoding myc3-tagged UBC4 wild type, C1S or C2S mutant were transformed into a
ubc4 ubc5 double mutant and transformants were grown on YNBcasD media. As controls, a
ubc5 single and a ubc4 ubc5 double mutant each carrying an empty vector were also tested for
growth. The picture was taken after 48 h. The slow growth phenotype seen in ubc4Δ ubc5Δ
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double mutant cells carrying an empty vector is not shared with the strains transformed with a
plasmid encoding any of the UBC4-myc3 (WT or mutant).
The steady-state level of Hap4 is increased in ubc4(C1S) mutant
To determine whether the C1S and C2S mutations in UBC4 affect Hap4 stability, we first
examined the effect of these two mutations on the steady-state level of Hap4. To this end, rho0
ubc1 ubc4 double mutant cells co-expressing Hap4-HA and Ubc4-myc, ubc4(c1S)-myc or
ubc4(C2)-myc were grown in YNBcasD or YNBcasR media and analyzed for Hap4 expression
by SDS-PAGE and immunoblotting. Figure 12 shows that the C1S mutation, not the C2S
mutation, significantly increases the steady-state level of Hap4, suggesting that the cysteine
residue 22 might be required for Hap4 degradation.

Figure 12: Hap4 Steady State Levels in ubc4 (Cys to Ser) Mutants
Rho0 ubc1Δ ubc4Δ strain containing plasmids encoding HAP4-HA and UBC4 alleles as indicated
were grown in dextrose or raffinose media and total cellular proteins was prepared using TCA
precipitation. The steady-state level of Hap4 was analyzed using immunoblotting. Pgk1 protein
levels were determined to show equal sample loading.
To determine whether the effect of the UBC4(C1S) mutant on Hap4 expression observed in
Figure 12 is post-translational or transcriptional, I determined the activity of a HAP4-lacZ
reporter gene, which provides information on HAP4 transcription, in ubc1 ubc4 double mutant
cells expressing myc-tagged wild-type UBC4, a C1S or a C2S mutant. Figure 13 shows that the
promoter activity of HAP4 is similar in cells expressing wild-type UBC4, the C1S or the C2S
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mutant. The data in Figure 12 and 13 provide evidence for a post-transcriptional mechanism
behind the increase in the steady-state level of Hap4 observed in the ubc4(C1S) mutant.

Figure 13: HAP4-lacZ promoter activity in ubc4 (Cys to Ser) mutation
Rho0 ubc1Δ ubc4Δ mutant cells containing plasmids encoding HAP4-lacZ and UBC4 alleles as
indicated were grown in dextrose or raffinose media and media and β-galactosidase activities
were determined as described in Methods and Materials.
Hap4 is stabilized due to a ubc4(C1S) mutation
To confirm that Hap4 is stabilized in a ubc4(C1S) mutant, I determined Hap4 stability in
ubc1 ubc4 double mutant cells expressing myc-tagged Ubc4 or a C1S mutant using
cycloheximide chase. Hap4 is destabilized in ubc1 ubc4 double mutant cells transformed with a
plasmid encoding UBC4-myc3 as compared to a control vector. In ubc1 ubc4 double mutant
cells transformed with a plasmid encoding the C1S mutant allele, Hap4 is dramatically stabilized.
This stabilization is comparable to that in the ubc1Δubc4Δ double mutant with a control vector.
Together, these data suggest that the cysteine residue 22 of Ubc4 is required for its activity
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Figure 14: ubc4(C1S) mutation leads to Hap4 stabilization
	
  
Rho0 ubc1Δ ubc4Δ strain containing plasmids encoding HAP4-HA and UBC4 alleles as indicated
were grown in raffinose media and Hap4 stability was analyzed by cycloheximide chase. Pgk1
protein levels were determined to show equal sample loading.

The ubc4(C1S) mutation affects Ubc4 modification
As a first step towards understanding the effect of a C1S mutation on Ubc4 activity, I
determined whether the C1S mutation affect post-translational modification of Ubc4. It has been
shown previously that Yap1 contains a redox active cysteine residue that causes mobility shift on
polyacrylamide gel. To observe whether similar modification exists to Ubc4, I prepared cellular
extracts without the use of reducing reagents. In cells expressing myc-tagged wild-type Ubc4
(WT) or a ubc4(C2S) mutant, Ubc4 exists as two distinct bands on Western blots. In contrast, the
ubc4(C1S) mutant exists as a single band, corresponding to the slower-mobility form of the wildtype Ubc4 or the C1S mutant. In samples prepared in the presence of the reducing reagents DTT
and β-mercaptoethanol, the fast-mobility form of Ubc4 disappears, suggesting that cysteine
residue 22 of Ubc4 might be involved in redox sensing.
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Rho+ and Rho0 ubc1Δ ubc4Δ strain containing a plasmid encoding myc-tagged wild-type UBC4,
a C1S or a C2S mutant were grown in YNBcasD or YNBcasR media and Ubc4 was analyzed for
Cycloheximide
Chase
Cycloheximide
Chase
post-translational modification
by immunoblotting.
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carried out using the reducing reagents dithiothreitol (DTT) and β-Mercaptoethanol (BME)
Vectorpreparation. For samples that received non-reducing treatment, no reducing
during sample
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rho cells, where respiratory growth is not possible due to loss of components of
pubc4In(C1S)
oxidative phosphorylation, it is energetically favorable for cells to repress the expression of
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nuclear genes involved in respiratory metabolism for efficient use of cellular resources. Hap4, as
the regulatory subunit of a major transcriptional activator of genes involved in oxidative
phosphorylation and mitochondrial biogenesis, is an ideal target for this repression. Selective
degradation of Hap4 as mediated through the UPS is largely implicated as the mechanism behind
the decreased Hap2-5 pathway activity seen in rho0 cells. The discrepancy seen in the half-life of
Hap4 in rho0 versus rho+ cells, which is not explained by Hap4 promoter activity, indicates a
post-translational mechanism mediating Hap4 stability. This implicates the UPS in controlling
the cellular response to dysfunctional mitochondria through increased degradation of Hap4.
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Of the 13 ubiquitin-conjugating E2 enzymes encoded in the yeast genome, Ubc4 and
Ubc5 are the main factors that mediate bulk protein degradation (Seufert & Jentsch, 1990). They
are also involved in targeting a number of short-lived, abnormal, misfolded proteins (Glickman
& Ciechanover, 2002). The redundant function of Ubc4 and Ubc5 is shared with Ubc1.
However, Ubc1 has been implicated in acting mostly in the early stages of cell growth and
therefore may have a more limited role in bulk protein degradation (Seufert, McGrath, &
Jentsch, 1990). In this study, I found that Ubc1 and Ubc4 play a redundant role in mediating
Hap4 degradation. Successful identification of the E2 enzymes responsible for Hap4 degradation
through the UPS opens the gateway to research on the factors and cellular mechanisms
regulating the selective targeting of Hap4 in response to mitochondria functional state.
Mitochondria are a major source of reactive oxygen species (ROS), which are produced
as byproducts of aerobic respiration. These byproducts include hydrogen peroxide (H2O2),
hydroxyl radicals (OH-), and the superoxide radical (O2-), all of which are highly reactive and
capable of damaging cellular components. There is a large debate in the scientific community
over the redox environment of rho0 cells. One school of thought suggests that due to decreased
respiratory activity, oxidative stress is reduced in cells lacking mtDNA (Chandel & Schumacker,
1999). However, it is also argued that the cellular environment is subject to increased oxidative
stress due to high concentrations of ROS produced due to blocks in the respiratory chain. Our
data shown in Figure 15 suggests that Ubc4 is oxidized via cysteine residue 22 based on its
similar modification to another well-studied protein Yap1.
A number of short-lived proteins have been shown to be subject to increased targeting by
Ubc4 and Ubc5 in response to oxidative stress (Medicherla & Goldburg, 2008). These enzymes
are also the only two E2s in the yeast genome that share the highly conserved cysteine 22 and
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108 cysteine residue (the numbering is based on Ubc4) (Figure 16). In combination with the
enzymes’ known overlapping functions, these observations suggest these two cysteine residues
are potential sites of regulation in response to changes in the cellular redox environment. As
previously stated, cysteine residues are rare in proteins and are often involved in cellular redox
sensing. This is accomplished at cysteine’s sulfhydryl group (SH), which responds to the
oxidative state of the cell through the formation of redox sensitive bonds either to another
cysteine residue (disulfide bonds) or is oxidized to sulfenic acid, sulfinic acid, or sulfonic acid.
Two proteins commonly involved in redox sensing are thioredoxin and glutaredoxin, both
of which exist in S. cerevisiae. These two proteins work in a similar manner to sense and respond
to oxidative stress for maintaining homeostasis of the cellular environment. Yeast have two types
of glutaredoxin proteins. The first of these consists of two oxioreductases, Grx1 and Gx2, both of
which contain two highly conserved redox-active cysteine residues. These proteins catalyze the
formation of protein mixed disulfides with glutathione, a prevalent cysteine modification
(Mieyal, Gallogly, Qanungo, Sabens, & Shelton). The other is a fairly novel group of three
proteins (Grx3,Grx4, and Grx5), which contain only a single active cysteine residue (Collinson,
Wheeler, Garrido, Avery, Avery, & Grant, 2002). As a mechanism catalyzed by a number of
highly conserved enzymes, further insight on the factors controlling the regulation of this system
has large implications in research on disease states such as diabetes, cancer, cardiovascular and
lung disease, and neurodegenerative disease (Mieyal, Gallogly, Qanungo, Sabens, & Shelton,
2008). This is particularly relevant due to the fact that oxidative stress is a ubiquitous occurrence
in all aerobic growing organisms, leading to conservation in the cellular responses to oxidative
damage (Jamieson, 1998).
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The fast migrating band seen in wild-type Ubc4 and the ubc4(C2S) mutant in Figure 15 is
similar to what is observed for Yap1, a transcription factor that is activated in response to
oxidative stress (Delaunay, Isnard, & Toledano, 2000). In Dr. Delaunay’s paper on Yap1’s role
in H2O2 sensing, evidence was provided for two conserved cysteine residues as playing a central
role in Yap1’s in vivo oxidation. In their research, an unknown cause results in the redoxdependent migration shift of Yap1 when run on non-reducing PAGE after treatment with H2O2,
but not with other oxidants (Delaunay, Isnard and Toledano, 2000). A similar model can be
proposed for Ubc4, whereby an unknown mechanism leads to oxidation of Ubc4 at cysteine
residue 22.
The research presented here has deep implications for the redox-sensing properties of
Ubc4, possibly through the redox-sensitive cysteine residue 22, as contributing to the regulation
of Hap2-5 pathway activity. Based on these findings, a novel model for Hap4 regulation can be
proposed, whereby the steady-state level of Hap4 is regulated through the redox regulation of
Ubc4.
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Figure 16: Sequence Alignment of Yeast’s Thirteen Ubc Enzymes
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Conclusion
The results of my research implicate post-translational regulation of Hap4 through the

UPS as the underlying mechanism regulating Hap4 levels in response to changes in
mitochondrial functional state. In this work, the isolation of the ubiquitin-conjugating enzymes
responsible for Hap4 degradation provides a novel mechanism for the regulation of
mitochondrial biogenesis in response to changes in the functional state of mitochondria. Through
mutant screening, the ubiquitin conjugating-enzymes, Ubc1 and Ubc4, were found to be the
primary E2s responsible for increased Hap4 instability in rho0 cells and subsequent downregulation of Hap2-5 target genes. Mutant analyses of two highly conserved cysteine residues of
Ubc4 led us to propose that regulation of Hap4 stability in response to changes in the cellular
respiratory function is mediated through redox-regulation of Ubc4.
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